Los Angeles Capital Management LLC Emergent Bio Solutions Inc. Transaction History

Los Angeles Capital Management LLC

$28.5 Billion
Q3 2025

A detailed history of Los Angeles Capital Management LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 134,900 shares of EBS stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

134,900

Holding current value

$1.36 Million

% of portfolio

0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	BUY	$5.63 - $9.32 $759,487 - $1.26 Million	134,900 New	134,900 $1.19 Million
Q2 2024 Aug 05, 2024	SELL	$1.86 - $6.98 $28,180 - $105,753	-15,151 Reduced 7.81%	178,840 $1.22 Million
Q1 2024 Apr 05, 2024	BUY	$1.5 - $3.41 $48,690 - $110,688	32,460 Added 20.1%	193,991 $490,000
Q4 2023 Feb 06, 2024	SELL	$1.82 - $3.16 $20,354 - $35,341	-11,184 Reduced 6.48%	161,531 $387,000
Q3 2023 Nov 06, 2023	BUY	$3.17 - $7.91 $263,097 - $656,498	82,996 Added 92.51%	172,715 $587,000

Q2 2023 Aug 03, 2023	BUY	$7.35 - $13.21 $332,624 - $597,818	45,255 Added 101.78%	89,719 $659,000
Q1 2023 May 04, 2023	BUY	$7.79 - $16.29 $346,374 - $724,318	44,464 New	44,464 $460,000
Q1 2022 May 06, 2022	SELL	$36.48 - $52.22 $318,579 - $456,037	-8,733 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$33.11 - $55.01 $294,414 - $489,148	-8,892 Reduced 50.45%	8,733 $380,000
Q3 2021 Nov 08, 2021	BUY	$50.07 - $66.05 $423,592 - $558,783	8,460 Added 92.31%	17,625 $882,000
Q2 2021 Aug 05, 2021	BUY	$56.61 - $80.46 $14,152 - $20,115	250 Added 2.8%	9,165 $577,000
Q1 2021 May 05, 2021	SELL	$86.23 - $125.19 $491,942 - $714,208	-5,705 Reduced 39.02%	8,915 $828,000
Q4 2020 Feb 04, 2021	SELL	$79.17 - $111.47 $17,338 - $24,411	-219 Reduced 1.48%	14,620 $1.31 Million
Q3 2020 Nov 02, 2020	BUY	$81.91 - $134.94 $36,040 - $59,373	440 Added 3.06%	14,839 $1.53 Million
Q2 2020 Aug 05, 2020	SELL	$54.33 - $89.52 $96,979 - $159,793	-1,785 Reduced 11.03%	14,399 $1.14 Million
Q4 2019 Feb 07, 2020	SELL	$51.21 - $59.06 $345,411 - $398,359	-6,745 Reduced 29.42%	16,184 $873,000
Q3 2019 Nov 07, 2019	SELL	$40.6 - $57.2 $8,120 - $11,440	-200 Reduced 0.86%	22,929 $1.2 Million
Q1 2019 Apr 25, 2019	SELL	$48.23 - $66.16 $13,986 - $19,186	-290 Reduced 1.24%	23,129 $1.17 Million
Q4 2018 Feb 11, 2019	SELL	$55.63 - $73.24 $234,758 - $309,072	-4,220 Reduced 15.27%	23,419 $1.39 Million
Q3 2018 Nov 05, 2018	SELL	$52.05 - $66.51 $92,232 - $117,855	-1,772 Reduced 6.02%	27,639 $1.82 Million
Q2 2018 Jul 31, 2018	SELL	$48.33 - $55.64 $206,369 - $237,582	-4,270 Reduced 12.68%	29,411 $1.49 Million
Q1 2018 Apr 27, 2018	SELL	$44.44 - $54.39 $1.34 Million - $1.65 Million	-30,255 Reduced 47.32%	33,681 $1.77 Million
Q4 2017 Feb 05, 2018	BUY	$37.77 - $47.75 $1.43 Million - $1.81 Million	37,874 Added 145.32%	63,936 $2.97 Million
Q3 2017 Nov 06, 2017	BUY	$34.14 - $40.45 $626,810 - $742,662	18,360 Added 238.38%	26,062 $1.05 Million
Q2 2017 Aug 09, 2017	BUY	N/A	7,702	7,702 $261,000

Others Institutions Holding EBS

# of Institutions

192

Shares Held

41.3M

Call Options Held

899K

Put Options Held

256K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Emergent Bio Solutions Inc. Transaction History